Welcome to the June 2025 edition of Digital Health Digest!Stay on the cutting edge of healthcare technology with our top stories this month. From multimillion-dollar funding rounds to AI assistants transforming workflows, these innovations…
Continue Reading
We reviewed 1016 FDA authorizations of AI/ML-enabled medical devices to develop a taxonomy capturing key variations in clinical and AI-related features. Quantitative image analysis remains the most common application, but its relative proportion has…
Continue Reading
What You Should Know:
– PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital…
Continue Reading
Private equity firm HealthpointCapital, which focuses on the musculoskeletal care sector, has acquired a majority stake in ImmersiveTouch, a medical extended reality (medical XR) company that enables surgeons to visualize and plan surgeries. Extended reality…
Continue Reading
Sora Neuroscience, a brain AI software company, announced it received FDA clearance for its Cirrus brain mapping software, which is used for helping neurosurgeons make clinical decisions. Cirrus uses functional magnetic resonance imaging (fMRI) to generate…
Continue Reading
Pharma giant Novo Nordisk announced that it is collaborating with WeightWatchers to offer Wegovy through NovoCare Pharmacy, effective July 1. Through the partnership, WeightWatchers’ telehealth program, integrated into NovoCare Pharmacy, will enable new uninsured or…
Continue Reading
Image Credit: bipartisanpolicy
What You Should Know:
– A new report from the Bipartisan Policy Center (BPC) examines the complex and often fragmented regulatory landscape for health AI tools that fall outside the jurisdiction of the…
Continue Reading
Atraverse Medical, a medical device company involved in minimally invasive cardiac procedures, announced the close of a $29.4 million follow-on financing.The raise expands upon $12.5 million in prior seed investment, which was utilized to…
Continue Reading
Revolutionary FDA Approval Marks Medical Milestone
Startup Clairity has achieved a groundbreaking milestone in healthcare technology, securing FDA approval for the agency’s first artificial intelligence tool specifically designed to predict five-year breast cancer risk from…
Diagnostic imaging company RadNet, via DeepHealth, its wholly-owned subsidiary, has acquired AI ultrasound imaging company See-Mode Technologies. See-Mode’s AI-powered ultrasound detection, characterization and reporting application for thyroid and breast will be integrated into RadNet’s DeepHealth…
Continue Reading
